Cleveland Clinic Brain Study with Dr. Imad Najm

One in every six people around the world live with a neurological disorder—a broad term used to describe things such as Alzheimer's disease, epilepsy, multiple sclerosis, or headaches. The first-of-its-kind Cleveland Clinic Brain Study is aiming to identify biomarkers of these disorders, so doctors can hopefully better predict who might develop a neurological disorder, potentially transforming the future of healthcare. Dr. Imad Najm, the study’s co-PI, discusses how the study came about, what makes the study so groundbreaking, and what other goals doctors hope to achieve.